IECM
OFIX icon

Intrinsic Edge Capital Management’s Orthofix Medical OFIX Stock Holding History

Intrinsic Edge Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-72,225
Closed -$3.41M – 148
2017
Q3 		$3.41M Sell
72,225
-8,973
-11% -$423K 0.67% 51
2017
Q2 		$3.77M Buy
+81,198
New +$3.37M 1.17% 31

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Intrinsic Edge Capital Management's OFIX Position: Q4 2017 in Review

Intrinsic Edge Capital Management sold out of Orthofix Medical (OFIX) in Q4 2017, closing a stake of 72,225 shares — an estimated $3.41M sold.

Intrinsic Edge Capital Management first reported a position in OFIX in Q2 2017 and held it in 2 quarters. The position peaked at $3.77M in Q2 2017. 164 funds tracked by Wall St. Rank hold OFIX as of Q4 2017.

  • Intrinsic Edge Capital Management reported no remaining Orthofix Medical position as of Q4 2017 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 72,225 Orthofix Medical shares in Q4 2017, an estimated $3.41M.
  • Intrinsic Edge Capital Management first reported a position in Orthofix Medical in Q2 2017 and held it in 2 quarters.
  • Intrinsic Edge Capital Management's Orthofix Medical position peaked at $3.77M in Q2 2017.
  • 164 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2017.

Based on Intrinsic Edge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.